key: cord-0763447-jgzodnfe
authors: Cosyns, Bernard; Motoc, Andreea; Arregle, Florent; Habib, Gilbert
title: A plea not to forget infective endocarditis in COVID-19 era
date: 2020-08-18
journal: JACC Cardiovasc Imaging
DOI: 10.1016/j.jcmg.2020.07.027
sha: 4a6b52efc7f178faff919228b0cd5c60716c482e
doc_id: 763447
cord_uid: jgzodnfe

nan

Although recent publications have stressed that the diagnosis and management of acute coronary syndrome should not be neglected during Coronavirus disease 2019 pandemic (1), the issue of infective endocarditis (IE) has not been addressed. IE is associated with a mortality rate of more than 20% and even 50% when surgery is indicated and not performed (2, 3) .

We compared the number of IE diagnosed in two regional tertiary reference centers from Belgium and France between January 24th 2020 (first COVID -19 case diagnosed in France) to April 30th 2020 (two weeks after the pandemic peak in France and Belgium) with the number of IE during the same timeframe last year. Additionally, we compared the rate of in-hospital complications and mortality between the two periods. Data were extracted from a dedicated database compiling all IE cases referred from these regions. This survey was approved by the local Ethical Committees of both centers and was carried out in accordance with the ethical principles for medical research involving human subjects established by Helsinki's Declaration, protecting the privacy of all participants.

The percentage of diagnosed IE decreased by 33% during the COVID-19 pandemic (47 patients in 2020 vs. 70 patients in 2019) ( Figure 1 ). Furthermore, we observed a worse prognosis in patients diagnosed with IE during the pandemic (i.e. cerebral embolism rate was 18.5% (13 patients) in 2019 vs. 56% (26 patients) in 2020). In -hospital IE mortality reached 61% (29 patients) during the pandemic vs. 31% in 2019 (22 patients), which was similar to EURO-ENDO registry results (2) . This probably also underlines that patients were referred late, but this hypothesis requires further analysis. IE is a deadly disease that requires a rigorous diagnostic and management approach.

Current guidelines recommend early surgery in patients with complicated IE (3). When surgery is indicated but not performed, the mortality is around 50% (2) .

Despite the fact that COVID -19 pandemic is the new priority for the healthcare systems worldwide, patients with IE may be at higher risk than before. Disregarding any SARS-CoV-2 co-infection, the patient with IE should be oriented towards an appropriate treatment pathway, 

The Untold Toll -The Pandemic's Effects on Patients without Covid-19

Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study

ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of

European Association for Cardio-Thoracic Surgery (EACTS), the European

COVID-19 pandemic and cardiac imaging: EACVI recommendations on precautions, indications, prioritization, and protection for patients and healthcare personnel. Eur Hear J -Cardiovasc Imaging